These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 27424432)
1. [Not Available]. Saillen E Rev Med Suisse; 2016 May; 12(519):1005. PubMed ID: 27424432 [No Abstract] [Full Text] [Related]
2. Are long-acting beta2-agonists safe in the treatment of asthma? Holgate ST Pol Arch Med Wewn; 2008 Sep; 118(9):460-1. PubMed ID: 18846978 [No Abstract] [Full Text] [Related]
5. Safety of long-acting beta-agonists. Currie GP Ann Intern Med; 2006 Nov; 145(9):707-8; author reply 708-10. PubMed ID: 17088590 [No Abstract] [Full Text] [Related]
6. Safety of long-acting beta-agonists. Nelson HS; Dorinsky PM Ann Intern Med; 2006 Nov; 145(9):706; author reply 708-10. PubMed ID: 17088589 [No Abstract] [Full Text] [Related]
7. The role of long-acting beta-agonists in the management of asthma: analysis, meta-analysis, and more analysis. Glassroth J Ann Intern Med; 2006 Jun; 144(12):936-7. PubMed ID: 16754915 [No Abstract] [Full Text] [Related]
8. Safety of long-acting beta-agonists. Ryan D Ann Intern Med; 2006 Nov; 145(9):707; author reply 708-10. PubMed ID: 17088592 [No Abstract] [Full Text] [Related]
9. [Role of particulate matter and small airways in treatment of asthma with inhalative fixcombinations]. Voshaar T Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S390-3. PubMed ID: 19941243 [No Abstract] [Full Text] [Related]
10. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids. Salpeter SR Expert Opin Drug Saf; 2010 May; 9(3):407-19. PubMed ID: 20408768 [TBL] [Abstract][Full Text] [Related]
13. [Interaction between inhaled corticosteroids and long-acting beta-2-agonists]. Kardos P Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S386-9. PubMed ID: 19941242 [No Abstract] [Full Text] [Related]
14. Call for withdrawal of LABA single-therapy inhaler in asthma. Beasley R; Perrin K; Weatherall M; Wijesinghe M Lancet; 2010 Sep; 376(9743):750-1. PubMed ID: 20816529 [No Abstract] [Full Text] [Related]
15. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?]. Buhl R Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241 [No Abstract] [Full Text] [Related]
16. Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Ortega VE; Peters SP Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285 [TBL] [Abstract][Full Text] [Related]
17. [Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]. Buhl R; Kardos P; Magnussen H; Matthys H; Sauer R; Schauer P; Vogelmeier C; Wettengel R; Worth H; Menz G Pneumologie; 1999 Apr; 53(4):210-2. PubMed ID: 10409864 [No Abstract] [Full Text] [Related]
18. Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events. Salpeter SR; Wall AJ; Buckley NS Am J Med; 2010 Apr; 123(4):322-8.e2. PubMed ID: 20176343 [TBL] [Abstract][Full Text] [Related]
19. [Asthma therapy in children. Value of long acting beta-mimetic drugs and anti-leukotrienes]. Nicolai T MMW Fortschr Med; 2000 Jun; 142(23):28-31. PubMed ID: 10900948 [TBL] [Abstract][Full Text] [Related]
20. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?]. Virchow C Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240 [No Abstract] [Full Text] [Related] [Next] [New Search]